Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aphria Inc. stock logo
APHA
Aphria
C$0.00
C$3.93
C$40.93
C$5.24BN/A6.16 million shs9.61 million shs
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$6.79
-0.6%
$5.66
$4.33
$8.00
$2.56B0.372.97 million shs2.16 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.26
+0.6%
$2.99
$2.28
$3.61
$1.19B0.941.70 million shs1.18 million shs
Cronos Group Inc stock logo
MJN
Cronos Group
C$12.15
-1.9%
C$12.15
C$1.58
C$14.83
C$1.73BN/A2.07 million shs1.39 million shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
-0.80%+7.71%+4.86%+26.33%-7.81%
Cronos Group Inc. stock logo
CRON
Cronos Group
+0.62%-3.83%+16.01%+18.98%+28.85%
Cronos Group Inc stock logo
MJN
Cronos Group
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aphria Inc. stock logo
APHA
Aphria
C$0.00
C$3.93
C$40.93
C$5.24BN/A6.16 million shs9.61 million shs
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$6.79
-0.6%
$5.66
$4.33
$8.00
$2.56B0.372.97 million shs2.16 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.26
+0.6%
$2.99
$2.28
$3.61
$1.19B0.941.70 million shs1.18 million shs
Cronos Group Inc stock logo
MJN
Cronos Group
C$12.15
-1.9%
C$12.15
C$1.58
C$14.83
C$1.73BN/A2.07 million shs1.39 million shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
-0.80%+7.71%+4.86%+26.33%-7.81%
Cronos Group Inc. stock logo
CRON
Cronos Group
+0.62%-3.83%+16.01%+18.98%+28.85%
Cronos Group Inc stock logo
MJN
Cronos Group
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aphria Inc. stock logo
APHA
Aphria
0.00
N/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
1.86
Reduce$8.0017.82% Upside
Cronos Group Inc. stock logo
CRON
Cronos Group
2.60
Moderate Buy$2.30-29.45% Downside
Cronos Group Inc stock logo
MJN
Cronos Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MJN, APHA, BHC, and CRON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
UpgradeHold (C+)Buy (B-)
8/20/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
UpgradeStrong SellHold
8/12/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
UpgradeSell (D+)Hold (C+)
7/31/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
UpgradeSell (D-)Sell (D)
7/24/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
DowngradeHoldStrong Sell
7/22/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
UpgradeHold
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aphria Inc. stock logo
APHA
Aphria
C$611.06M0.00N/A22.40C$4.76 per share0.00
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$10.27B0.25$7.22 per share0.94($2.14) per share-3.17
Cronos Group Inc. stock logo
CRON
Cronos Group
$146.59M8.20$0.01 per share258.44$3.01 per share1.08
Cronos Group Inc stock logo
MJN
Cronos Group
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aphria Inc. stock logo
APHA
Aphria
N/A-C$2.01N/AN/AN/AN/AN/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$157M-$2.96N/A1.69N/A-10.12%-561.95%6.31%10/28/2026 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
-$9.45M$0.2016.30N/AN/A39.08%4.85%4.62%11/5/2026 (Estimated)
Cronos Group Inc stock logo
MJN
Cronos Group
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest MJN, APHA, BHC, and CRON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.09+$0.08$0.09$44.20 million$53.01 million
7/29/2026Q2 2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.96$1.26+$0.30$0.68$2.59 billion$2.83 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Cronos Group Inc stock logo
MJN
Cronos Group
C$1.6513.58%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aphria Inc. stock logo
APHA
Aphria
59.29
3.37
1.63
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
54.68
1.44
1.08
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
16.18
15.25
Cronos Group Inc stock logo
MJN
Cronos Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aphria Inc. stock logo
APHA
Aphria
N/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
78.65%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Cronos Group Inc stock logo
MJN
Cronos Group
N/A

Insider Ownership

CompanyInsider Ownership
Aphria Inc. stock logo
APHA
Aphria
N/A
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20.67%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.80%
Cronos Group Inc stock logo
MJN
Cronos Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aphria Inc. stock logo
APHA
Aphria
1,200316.80 millionN/ANot Optionable
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20,300374.13 million296.80 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450368.54 million339.80 millionOptionable
Cronos Group Inc stock logo
MJN
Cronos Group
7,600142.65 millionN/ANot Optionable

Recent News About These Companies

Spinach® is the Number One Vape Brand in Canada
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
Canaccord is Bullish on Cronos Group Inc. (CRON)
Canaccord is Bullish on Cronos Group Inc. (CRON)
Cronos Group Releases 2025 Second Quarter Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aphria stock logo

Aphria TSE:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Bausch Health Cos stock logo

Bausch Health Cos NYSE:BHC

$6.79 -0.04 (-0.59%)
Closing price 09/3/2026 03:58 PM Eastern
Extended Trading
$6.88 +0.09 (+1.37%)
As of 04:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$3.26 +0.02 (+0.62%)
As of 09/3/2026 04:00 PM Eastern

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Cronos Group stock logo

Cronos Group CVE:MJN

C$12.15 -0.23 (-1.86%)
As of 03/2/2018

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.